8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2005 / Uncontrolled clinical trial
Twenty-four patients with late-stage terminal cancer received continuous intravenous ascorbate infusions ranging from 150 to 710 mg/kg/day for up to eight weeks. Infusions raised mean plasma ascorbate to 1.1 mM. Most adverse events were minor, such as nausea, edema, and dry mouth or skin. Two potentially related grade 3 events occurred: a kidney stone in a patient with a history of renal calculi and hypokalemia in another.
Riordan HD, Casciari JJ, González MJ, et al. P R Health Sci J, 2005. PMID 16570523
2004 / Dietary intervention trial
Healthy volunteers received dietary interventions consisting of a mixed carotene capsule, cooked minced carrots, matched placebo, mandarin oranges, or vitamin C tablets. No dietary intervention altered baseline levels of single-strand breaks (SSB), provided direct antioxidant protection, or altered DNA repair capacity, with two exceptions. Post-H2O2 SSB decreased more rapidly in lymphocytes from volunteers given mixed carotene capsules, and repair patch synthesis activity increased in lymphocytes from volunteers given cooked carrots.
Astley SB, Elliott RM, Archer DB, et al. Br J Nutr, 2004. PMID 14748939
2004 / Pilot single-arm intervention study
Fifteen men scheduled for repeat prostate biopsy followed a low-fat (<20% kcal), flaxseed-supplemented (30 g/day) diet for 6 months. Statistically significant decreases were observed in PSA (8.47 +/- 3.82 to 5.72 +/- 3.16 ng/mL; P = 0.0002) and cholesterol (241.1 +/- 30.8 to 213.3 +/- 51.2 mg/dL; P = 0.012), while total testosterone showed no significant change. Among 13 men undergoing repeat biopsy, proliferation rates in benign prostatic epithelium decreased significantly from 0.022 +/- 0.027 to 0.007 +/- 0.014 (P = 0.0168).
Demark-Wahnefried W, Robertson CN, Walther PJ, et al. Urology, 2004. PMID 15134976
2004 / Randomized controlled trial
In this trial, 34 of 37 premenopausal women completed an evaluation lasting over two menstrual cycles. Participants received either a placebo or daily supplements providing Lactobacillus acidophilus and Bifidobacterium longum. The probiotic intervention did not significantly change urinary equol excretion or plasma reproductive hormone concentrations, although nonsignificant downward trends occurred for testosterone (P=0.14) and sex-hormone-binding globulin (P=0.10).
Bonorden MJ, Greany KA, Wangen KE, et al. Eur J Clin Nutr, 2004. PMID 15213709
2004 / Randomized double-blind trial
A double-blind trial assigned 58 head-and-neck cancer patients undergoing curative radiation therapy to receive oral aloe vera gel or a placebo. At treatment conclusion, both cohorts demonstrated statistically indistinguishable maximal toxicity grades, mucositis duration, pain medication usage, weight changes, and quality-of-life scores. Oral aloe vera did not decrease mucosal soreness, diminish oral tissue inflammation, or improve radiotherapy tolerance.
Su CK, Mehta V, Ravikumar L, et al. Int J Radiat Oncol Biol Phys, 2004. PMID 15337553
2004 / Randomized controlled trial
Twenty-nine men with prostate cancer scheduled for radical prostatectomy consumed bread with heat-treated soy grits, soy grits plus linseed, or wheat. The soy grits group had significantly different percentage changes in total PSA (-12.7% versus 40%, P = 0.02) and free/total PSA ratio (27.4% versus -15.6%, P = 0.01) compared to wheat control. Differences in free androgen index and free/total PSA ratio were also found between soy and soy plus linseed.
Dalais FS, Meliala A, Wattanapenpaiboon N, et al. Urology, 2004. PMID 15351581
2003 / Phase II clinical trial
In a phase II trial, 42 patients with androgen-independent prostate carcinoma took 6 grams of oral green tea daily in divided doses. Only one patient (2%, 95% CI 1-14%) experienced a tumor response, defined as at least a 50% drop in prostate-specific antigen, and it lasted under two months. Median prostate-specific antigen values increased by 43% by one month. Adverse events occurred in 69% of participants.
Jatoi A, Ellison N, Burch PA, et al. Cancer, 2003. PMID 12627508
2003 / Controlled study
A controlled study evaluated intestinal N-nitrosation in 21 healthy male volunteers across different diets. Fecal N-nitroso compounds were higher on a high red meat diet of 420 g than on a 60 g meat diet (P = 0.001), but vegetable protein had no effect. An 8-mg haem iron supplement raised fecal compounds (P = 0.006), whereas 35 mg of inorganic iron did not.
Cross AJ, Pollock JR, Bingham SA Cancer Res, 2003. PMID 12750250
2003 / Controlled clinical study with in vitro assay
Serum was collected from men in control, diet plus exercise, and exercise-alone groups to stimulate LNCaP cells in culture. Both intervention groups showed lower serum insulin and IGF-1 along with higher IGFBP-1 compared to controls. In vitro, LNCaP cell growth decreased and apoptosis increased when cultured with serum from men in the intervention groups.
Barnard RJ, Ngo TH, Leung PS, et al. Prostate, 2003. PMID 12772189
2003 / Controlled clinical trial
Researchers evaluated green tea extracts (polyphenon E ointment or capsule, or EGCG capsule) administered for 8 to 12 weeks in 51 patients with cervical lesions alongside 39 untreated controls. Overall, treated patients showed a 69% response rate (35 of 51) compared to a 10% response rate (4 of 39) in untreated controls (P < 0.05). Response rates reached 74% with ointment alone, 75% with ointment plus capsule, and 60% with EGCG capsules.
Ahn WS, Yoo J, Huh SW, et al. Eur J Cancer Prev, 2003. PMID 14512803
2003 / Randomized controlled pilot trial
Ten men with conservatively treated prostate cancer were randomized to 295 g of rye bran bread daily and eight men to 275 g of wheat bread with similar fiber content for 3 weeks. In the rye group, plasma enterolactone increased significantly, and the apoptotic index rose from 2.1% (SD 1.3) to 5.9% (SD 1.8), P<0.005, based on a TUNEL index in four rye and seven control cases. Both groups had a significant decrease in weight, with only small changes in PSA, circulating sex hormones, excreted oestrogens, IGF-I, and the endothelial fibrinolytical system.
Bylund A, Lundin E, Zhang JX, et al. Eur J Cancer Prev, 2003. PMID 14512806
2003 / Randomized controlled trial
In a randomized trial, 143 heavy smokers consumed four cups daily of decaffeinated green tea, black tea, or water for four months, with 133 completing the trial. After adjusting for baseline levels and confounders, green tea intake led to a 31% reduction in creatinine-adjusted urinary 8-hydroxydeoxyguanosine (P = 0.002). Conversely, black tea consumption did not alter levels of this oxidative damage marker.
Hakim IA, Harris RB, Brown S, et al. J Nutr, 2003. PMID 14519830
2003 / Human feeding study with cell and tissue assays
Using a specific antibody and mass spectrometry, researchers detected small amounts of the nonhuman sialic acid Neu5Gc in human fetal tissues, normal adult tissues, and breast carcinomas. In vitro, human cells fed Neu5Gc incorporated it into endogenous glycoproteins. When normal human volunteers ingested Neu5Gc, a portion was absorbed, eliminated in urine, and incorporated in small quantities into newly synthesized glycoproteins. Analysis of food sources indicated Neu5Gc was enriched in red meats, common in milk products, and rare in poultry and fish. Additionally, normal humans demonstrated variable levels of circulating IgA, IgM, and IgG antibodies against Neu5Gc.
Tangvoranuntakul P, Gagneux P, Diaz S, et al. Proc Natl Acad Sci U S A, 2003. PMID 14523234
2002 / Randomized placebo-controlled trial
A total of 20,536 high-risk UK adults were randomly allocated to receive daily antioxidant vitamins (600 mg vitamin E, 250 mg vitamin C, and 20 mg beta-carotene) or placebo for 5 years. There were no significant differences in all-cause mortality (14.1% vitamin vs 13.5% placebo), vascular deaths (8.6% vs 8.2%), or non-vascular deaths (5.5% vs 5.3%). Major vascular events occurred in 22.5% of participants in both the vitamin and placebo groups (event rate ratio 1.00, 95% CI 0.94-1.06). There were also no significant effects observed on cancer incidence or hospitalisation for other non-vascular causes.
Heart Protection Study Collaborative Group Lancet, 2002. PMID 12114037
2002 / Randomized crossover trial
Eleven male volunteers consuming a high red meat diet (420 g/day) were studied across randomized 15-day dietary periods evaluating vegetables (400 g/day) and tea extract (3 g/day), with seven completing an additional soy period (100 g/day). Soy significantly suppressed fecal ATNC concentration (P = 0.02), whereas vegetables and tea extract did not affect mean levels of fecal ATNC, nitrogen, ammonia excretion, or fecal water genotoxicity. Vegetables increased fecal weight (P < 0.001), which was linked to reduced transit time (r = 0.594, P < 0.0001); longer transit times correlated with elevated fecal ATNC (r = 0.42, P = 0.002). Fecal nitrite was significantly reduced by tea compared to meat-only (P = 0.0028) and meat plus vegetables (P = 0.005).
Hughes R, Pollock JR, Bingham S Nutr Cancer, 2002. PMID 12235653
2002 / Open-label clinical trial
Sixty-two men with histologically proven prostate cancer and elevated PSA received shiitake mushroom mycelium extract capsules three times daily for 6 months. Among 61 assessable patients, zero achieved a complete or partial PSA response, 23 developed disease progression, and 38 maintained stable PSA levels. When pre-study PSA trajectories were examined, only 4 of 61 patients (7%) demonstrated stabilized disease while taking the supplement.
deVere White RW, Hackman RM, Soares SE, et al. Urology, 2002. PMID 12385925
2002 / Controlled feeding study
Volunteers were fed controlled diets with varying levels of meat to examine endogenous N-nitrosation. Equivalent amounts (420-600 g) of white meat had no effect on fecal ATNCs in 12 volunteers (P = 0.338). In contrast, doses of 0, 60, 120, 240, and 420 g red meat/day showed that mean ATNC output was highly correlated with meat dose (for concentration, r = 0.972, beta = 0.252 ng/g; for total output, r = 0.963, beta = 2.605 microg/d).
Bingham SA, Hughes R, Cross AJ J Nutr, 2002. PMID 12421881
2002 / Nonrandomized single-arm intervention trial
Thirty-two patients with localized prostate adenocarcinoma consumed tomato sauce-based pasta dishes providing 30 mg lycopene daily for 3 weeks before radical prostatectomy. Serum and prostate lycopene increased 1.97- and 2.92-fold, respectively (P < 0.001), while mean serum PSA decreased by 17.5% (P < 0.002) and leukocyte 8OHdG decreased by 21.3% (P < 0.005). Resected tissues showed 28.3% lower prostate 8OHdG than controls (P < 0.03), and cancer cell 8OHdG staining was reduced by 40.5% in mean nuclear density and 36.4% in mean area compared to baseline biopsy.
Bowen P, Chen L, Stacewicz-Sapuntzakis M, et al. Exp Biol Med (Maywood), 2002. PMID 12424330
2002 / Intervention trial with an observational long-term comparison group
Fasting serum was obtained from 14 men completing an 11-day low-fat diet and exercise (DE) program and 8 men who had followed the program for 14.2 +/- 1.7 years. After the 11-day intervention, serum IGF-I decreased by 20%, IGFBP-1 increased by 53%, and insulin decreased by 25%. In the long-term group relative to baseline, IGF-I was 55% lower, IGFBP-1 was 150% higher, and insulin was 68% lower, with no changes in IGFBP-3 in either group. Serum-stimulated LNCaP prostate cancer cell growth in vitro fell by 30% with post-11-day serum and by 44% with long-term serum, alongside increased apoptosis/necrosis.
Ngo TH, Barnard RJ, Tymchuk CN, et al. Cancer Causes Control, 2002. PMID 12588089
2001 / Randomized controlled feeding trial
In eight male volunteers fed randomized controlled diets over 10-day periods, increasing meat doses from 0 to 60, 240, and 420 g/day significantly increased faecal apparent total N-nitroso compounds (ATNC; P < 0.0001) and nitrite excretion (P = 0.046). Mean (+/- SE) faecal ATNC levels were 54 +/- 7 microg/day at 0 g meat, 52 +/- 11 microg/day at 60 g/day, 159 +/- 33 microg/day with 240 g meat, and 199 +/- 36 microg/day with 420 g meat. Higher concentrations of NOC were associated with longer gut transit times (r = 0.55, P = 0.001) and low faecal weight (r = -0.51, P = 0.004). Levels did not significantly decline in individuals fed 420 g meat for 40 days.
Hughes R, Cross AJ, Pollock JR, et al. Carcinogenesis, 2001. PMID 11159760
2001 / Phase 1 clinical trial
A phase I trial assessed the safety and pharmacokinetics of oral green tea extract in 49 adults with solid tumors over four weeks to six months. The maximum tolerated intake reached 4.2 g/m² given once per day or 1.0 g/m² taken thrice daily. Side effects were mild to moderate, primarily caffeine-related, and 10 individuals achieved stable disease.
Pisters KM, Newman RA, Coldman B, et al. J Clin Oncol, 2001. PMID 11251015
2001 / Randomized dietary intervention study
Thirty-five men were randomly assigned to consume 400 ml of soymilk daily for 8 weeks or maintain their usual diet, with blood samples drawn over 12 weeks. Estimated mean intake was 342.9 (SD, 74.2) ml in the soymilk group. A significant difference was observed between groups for serum estrone changes, which tended to decrease in the soy group and increase in controls, while estradiol, total and free testosterone, and sex hormone-binding globulin showed no statistical differences.
Nagata C, Takatsuka N, Shimizu H, et al. Cancer Epidemiol Biomarkers Prev, 2001. PMID 11303585
2001 / Controlled clinical trial (single-arm intervention with historical controls)
Twenty-five men awaiting prostatectomy followed a low-fat diet supplemented with 30 g/day of flaxseed for an average of 34 days. Participants had significant reductions in total cholesterol (from 201 to 174 mg/dL), total testosterone (from 422 to 360 ng/dL), and free androgen index (from 36.3% to 29.3%; all p < 0.05). Compared with historical controls, dietary treatment was linked to lower tumor proliferation (5.0 vs. 7.4; p = 0.05) and significantly altered apoptotic indices (p = 0.01), with no significant change in overall PSA.
Demark-Wahnefried W, Price DT, Polascik TJ, et al. Urology, 2001. PMID 11445478
2001 / Dose-escalation pilot clinical trial
Fifteen patients with advanced colorectal cancer received 440 to 2,200 mg daily of Curcuma extract for up to 4 months. Neither curcumin nor metabolites were detectable in blood or urine, though curcumin was found in feces. A dose of 440 mg reduced lymphocytic glutathione S-transferase by 59% at day 29, but higher doses did not, and five patients had radiologically stable disease for 2-4 months.
Sharma RA, McLelland HR, Hill KA, et al. Clin Cancer Res, 2001. PMID 11448902